Amicus Therapeutics Management
Management criteria checks 2/4
Amicus Therapeutics' CEO is Brad Campbell, appointed in Jan 2015, has a tenure of 8.25 years. total yearly compensation is $4.91M, comprised of 11.2% salary and 88.8% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth MX$84.57M. The average tenure of the management team and the board of directors is 6.1 years and 5.8 years respectively.
Key information
Brad Campbell
Chief executive officer
US$4.9m
Total compensation
| CEO salary percentage | 11.2% |
| CEO tenure | 8.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | 6.1yrs |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -US$237m |
| Sep 30 2022 | n/a | n/a | -US$264m |
| Jun 30 2022 | n/a | n/a | -US$281m |
| Mar 31 2022 | n/a | n/a | -US$270m |
| Dec 31 2021 | US$5m | US$551k | -US$250m |
| Sep 30 2021 | n/a | n/a | -US$239m |
| Jun 30 2021 | n/a | n/a | -US$252m |
| Mar 31 2021 | n/a | n/a | -US$254m |
| Dec 31 2020 | US$5m | US$516k | -US$277m |
| Sep 30 2020 | n/a | n/a | -US$295m |
| Jun 30 2020 | n/a | n/a | -US$293m |
| Mar 31 2020 | n/a | n/a | -US$325m |
| Dec 31 2019 | US$4m | US$501k | -US$356m |
| Sep 30 2019 | n/a | n/a | -US$345m |
| Jun 30 2019 | n/a | n/a | -US$442m |
| Mar 31 2019 | n/a | n/a | -US$419m |
| Dec 31 2018 | US$3m | US$468k | -US$349m |
| Sep 30 2018 | n/a | n/a | -US$340m |
| Jun 30 2018 | n/a | n/a | -US$293m |
| Mar 31 2018 | n/a | n/a | -US$279m |
| Dec 31 2017 | US$2m | US$450k | -US$284m |
| Sep 30 2017 | n/a | n/a | -US$273m |
| Jun 30 2017 | n/a | n/a | -US$208m |
| Mar 31 2017 | n/a | n/a | -US$211m |
| Dec 31 2016 | US$2m | US$427k | -US$200m |
Compensation vs Market: Brad's total compensation ($USD4.91M) is above average for companies of similar size in the MX market ($USD1.61M).
Compensation vs Earnings: Brad's compensation has increased whilst the company is unprofitable.
CEO
Brad Campbell (46 yo)
8.3yrs
Tenure
US$4,911,455
Compensation
Mr. Bradley L. Campbell, also known as Brad, MBA, serves as Director of Gennao Bio, Inc. since March 2022. He serves as Director of Alliance for Regenerative Medicine. He served as Chief Operating Officer...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 18.7yrs | US$9.99m | 0.37% $ 214.1m | |
| CEO, President & Director | 8.3yrs | US$4.91m | 0.14% $ 84.6m | |
| Chief Financial Officer | 4.3yrs | US$3.06m | 0.088% $ 51.5m | |
| Chief Legal Officer & Corporate Secretary | 7.2yrs | US$3.05m | 0.049% $ 28.7m | |
| Chief People Officer | 4.5yrs | US$2.62m | 0.039% $ 22.5m | |
| VP, Global Controller & Principal Accounting Officer | 5.1yrs | no data | 0.029% $ 17.1m | |
| Chief Science Officer | no data | no data | no data | |
| Senior Director of Investor Relations | no data | no data | no data | |
| Global Chief Compliance & Risk Officer | 7.7yrs | no data | no data | |
| Head of Global Corporate Communications | no data | no data | no data | |
| Chief Patient Advocate | 7.6yrs | no data | no data | |
| Chief Development Officer | no data | no data | 0.078% $ 45.5m |
6.1yrs
Average Tenure
52.5yo
Average Age
Experienced Management: FOLD *'s management team is seasoned and experienced (6.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 18.7yrs | US$9.99m | 0.37% $ 214.1m | |
| CEO, President & Director | 4.8yrs | US$4.91m | 0.14% $ 84.6m | |
| Independent Director | 3.8yrs | US$390.00k | 0.022% $ 13.0m | |
| Independent Director | 2.3yrs | US$390.00k | 0.0051% $ 3.0m | |
| Independent Director | 16.8yrs | US$402.50k | 0.016% $ 9.5m | |
| Independent Director | 13.5yrs | US$400.00k | 0.0056% $ 3.3m | |
| Independent Director | 6.8yrs | US$394.99k | 0.011% $ 6.4m | |
| Lead Independent Director | 19.3yrs | US$428.28k | 0.017% $ 9.8m | |
| Independent Director | 1.8yrs | US$522.36k | 0.0020% $ 1.2m | |
| Independent Director | 4.6yrs | US$395.00k | 0.013% $ 7.9m |
5.8yrs
Average Tenure
60.5yo
Average Age
Experienced Board: FOLD *'s board of directors are considered experienced (5.8 years average tenure).